Budapest, Hungary

Kalmen Harsanyi


Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kalmen Harsanyi: Innovator in Antihyperlipoproteinemic Research

Introduction

Kalmen Harsanyi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating hyperlipoproteinemic diseases. His work is characterized by a focus on innovative solutions to complex health issues.

Latest Patents

Harsanyi holds a patent for an invention titled "Antihyperlipoproteinemic 5-substituted sulfur-containing benzimidazole." This invention relates to novel, sulfur-containing 5-substituted benzimidazole derivatives and their acid-addition salts, which exhibit antihyperlipoproteinemic action. The patent outlines a process for preparing these compounds, pharmaceutical formulations that include the novel compound as an active ingredient, and methods for inhibiting atherosclerosis and thrombus formation.

Career Highlights

Kalmen Harsanyi is associated with Richter Gedeon Vegyeszeti Gyar Rt, a prominent pharmaceutical company in Hungary. His work at the company has allowed him to focus on research and development in the pharmaceutical sector, contributing to advancements in medical treatments.

Collaborations

Harsanyi has collaborated with several professionals in his field, including Andrea Maderspach and Andres Javor. These collaborations have likely enhanced the scope and impact of his research efforts.

Conclusion

Kalmen Harsanyi's innovative work in antihyperlipoproteinemic research exemplifies the importance of pharmaceutical advancements in treating complex health conditions. His contributions continue to influence the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…